Company Filing History:
Years Active: 2013-2023
Title: Innovations and Contributions of Derek R Duckett
Introduction
Derek R Duckett is a notable inventor based in Jupiter, Florida, with a significant contribution to the field of cancer research. He holds a total of four patents, showcasing his innovative approach to developing therapeutic methods for various cancers.
Latest Patents
Among his latest patents, Duckett has developed small molecule inhibitors of CDK12/CDK13. This invention provides compounds and methods for inhibiting cyclin-dependent kinases, which can be highly selective inhibitors relative to other kinases. These compounds are particularly useful in treating cancers such as breast cancer, brain cancer, and ovarian cancer. Another significant patent focuses on therapeutic targeting of casein kinase 1δ in breast cancer. This invention outlines a method for inhibiting CK1δ, demonstrating its potential in treating various cancer types, including triple-negative breast cancer and HER+ breast cancer.
Career Highlights
Duckett has worked with prestigious institutions such as The Scripps Research Institute and the University of Florida Research Foundation. His work has contributed to advancements in cancer treatment methodologies, emphasizing the importance of targeted therapies.
Collaborations
Duckett has collaborated with notable colleagues, including Theodore M Kamenecka and Rong Jiang, further enhancing the impact of his research in the scientific community.
Conclusion
Derek R Duckett's innovative contributions to cancer research through his patents and collaborations highlight his commitment to advancing medical science. His work continues to pave the way for new therapeutic strategies in the fight against cancer.